BENSALEM, Pa.–(BUSINESS WIRE)–Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended September 30, 2022 revenue of $414.5 million and net income of $0.3 million. The Company’s Board of Directors declared a quarterly cash dividend of $0.215 per common share, the 77th consecutive increase since the initiation of dividend payments in 2003. … [Read more…]
One-year data from clinical IDE trial published in Clinical Spine Surgery proves lumbar facet arthroplasty with TOPS device maintains motion at index surgical level NORWALK, Conn.–(BUSINESS WIRE)–#Spondylolthesis—Premia Spine, a medical technology company changing the way debilitating chronic leg and back pain is treated, today announced publication of one-year outcomes from the TOPS facet replacement system’s … [Read more…]
FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2022, after the close of market on Wednesday, Nov. 2, 2022. Company management will host a conference … [Read more…]
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 after the market close. STAAR will host a conference call … [Read more…]
BOSTON–(BUSINESS WIRE)–908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the third quarter 2022 before market open on Monday, November 14, 2022. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time … [Read more…]
– Board appointments following recent $95 million CAD Series C Financing MONTREAL–(BUSINESS WIRE)–#EdMathers–Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced the appointment of two new board members: Ed Mathers, BSc, General Partner at New Enterprise Associates (“NEA”) and Nanna Lüneborg, PhD, MBA, General … [Read more…]
Third quarter GAAP net income was $6.68 per share, including net negative adjustment items of $0.85 per share. Adjusted net income was $7.53* per share. Operating revenue grew 11.5% over the prior year quarter to $39.6 billion. Operating gain grew 10.2% over the prior year quarter to $2.3 billion. Medical enrollment increased 2.2 million members … [Read more…]
AUSTIN, Texas, SOUTH SAN FRANCISCO & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer, today announced a multi-year agreement with AmplifyBio to use its facilities in South San Francisco, Calif. for Triumvira to … [Read more…]
AUSTIN, Texas–(BUSINESS WIRE)–#clinicalpanel–Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers’ compensation pharmacy benefits manager, ProdigyRx. The panel brings expertise in a wide range of pharmacy management areas to support ProdigyRx’s clinical programs, evaluate emerging therapies, and consult on extremely complex cases. Initial members are Maud Boateng, Pharm.D., … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Kidney Cancer Drugs Market, by Therapy, by Pharmacological Class, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Clear cell renal cell carcinoma is the most common form of renal cell carcinoma. When seen in the lab, the cells … [Read more…]
